Summit Therapeutics Stock Forecast

Buy or Hold candidate since Jul 02, 2026 Loss -2.27%

The Summit Therapeutics plc stock price fell by -2.59% on the last day (Wednesday, 15th Jul 2026) from $15.47 to $15.07. During the last trading day the stock fluctuated 4.55% from a day low at $14.94 to a day high of $15.62. The price has fallen in 6 of the last 10 days but is still up by 3.43% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -733 thousand shares and in total, 2 million shares were bought and sold for approximately $34.69 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -33.78% during the next 3 months and, with a 90% probability hold a price between $6.38 and $11.76 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SMMT Signals & Forecast

The Summit Therapeutics plc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $15.45. On a fall, the stock will find some support from the long-term average at approximately $14.93. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 15.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Summit Therapeutics plc stock

Summit Therapeutics plc finds support from accumulated volume at $14.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.680 between high and low, or 4.55%. For the last week, the stock has had daily average volatility of 3.86%.

Our recommended stop-loss: $14.34 (-4.85%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 23 days ago.)

Trading Expectations (SMMT) For The Upcoming Trading Day Of Thursday 16th

For the upcoming trading day on Thursday, 16th we expect Summit Therapeutics plc to open at $15.21, and during the day (based on 14 day Average True Range), to move between $14.69 and $15.45, which gives a possible trading interval of +/-$0.762 (+/-5.19%) up or down from last closing price. If Summit Therapeutics plc takes out the full calculated possible swing range there will be an estimated 5.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $14.86 (1.39%) than the resistance at $15.71 (4.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Summit Therapeutics plc stock A Buy?

Summit Therapeutics plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.356 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 16, 2026 - $15.21 ( 0.93%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk